Laura Davis
Surgical · Austin, TXNPI 1780691063
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,830 of the $4,842 with a category attached, or 79.1%. 24 manufacturers reported payments, led by AbbVie at 31.6% of the total. Reporting peaked in 2024 at $2,245 and has fallen 56.0% since, to $988 in 2025. Among surgical clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $39.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Myriad Genetic Laboratories, Inc.$923
- AstraZeneca$355
- Immunogen, Inc.$289
- Merck$244
- GSK$239
- plus $1K from 18 others
What the payments were for
- Consulting fees$1,01321%
- Food & beverage$3,83079%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $1,529 |
| Myriad Genetic Laboratories, Inc. | 35 | $923 |
| AstraZeneca | 13 | $355 |
| Immunogen, Inc. | 3 | $289 |
| Merck | 9 | $244 |
| GSK | 8 | $239 |
| Medtronic | 1 | $170 |
| Seagen Inc. | 6 | $159 |
| Johnson & Johnson | 6 | $138 |
| E.r. Squibb & Sons, L.L.C. | 6 | $138 |
| Eisai Inc. | 5 | $112 |
| Tempus AI, Inc | 2 | $101 |
| Pfizer | 4 | $74 |
| Novartis | 3 | $74 |
| Astellas Pharma US Inc | 2 | $50 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Incyte Corporation | 2 | $44 |
| Edwards Lifesciences | 1 | $39 |
| Lilly USA, LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Clovis Oncology, Inc. | 1 | $18 |
| Sobi, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elahere$1,677
- myRisk$343
- INTELLIS ADAPTIVESTIM$170
- PreciseTumor$115
How this compares
$4,842 in reported general payments places this provider in the 90th percentile of 804 surgical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 12 | $4,972 |
| Megestrol Acetate | 12 | $966 |
| Gabapentin | 38 | $331 |
| Levothyroxine Sodium | 33 | $202 |
| Lorazepam | 15 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $50 | $4,97212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 804 surgical providers in Texas.
Other surgical in Austin
- Courtney DunavantAustin$389K
- Henry KinnebrewAustin$40K
- Sarah IragorriAustin$18K
- Cameron PratherAustin$12K
- Vanessa ScialomAustin$8K
- Valerie CavazosAustin$6K
- Jennifer ClarnerAustin$6K
- Kevin GiacontiereAustin$5K
- Brant VictorAustin$5K
- Heidi BurnsAustin$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.